Eurofarma Synapsis announces the selected scale-ups
Published in: July 29, 2019
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, July 2019 – The second edition of Eurofarma Synapsis, Eurofarma's acceleration program aimed at supporting entrepreneurship in Latin America and encouraging healthcare innovation, enters the mentoring phase with the eight scale-ups already defined. This second edition had 194 companies registered, a number that represents a qualification of the candidate scale-ups within a more specific performance.
The selected companies presented solutions to contribute to process improvement and efficiency in healthcare chain productivity, focusing on Business Intelligence, shared services, commercial and marketing, industrial operations and sustainability. Below is a list of the chosen scale-ups:
From August, scale-ups will be mentored by Endeavor, a global non-profit organization that has been a partner of Eurofarma in the program for four months. Selected companies will be able to leverage their business by having industry information and trends available, coaching in support areas such as marketing, sales and logistics, and access to Eurofarma's relationship network. There are more than 4,000 suppliers, more than 1,500 active clients (B2B), almost 600,000 medical contacts per month and a presence with healthcare products and services in 20 Latin American countries. Then the chosen companies will start to implement a pilot project with Eurofarma so that they will have the opportunity to close a long-term contract later.
“We performed a careful assessment regarding the entrepreneur profile and its team, the degree of innovation and business model presented, considering the impact it can generate within Eurofarma. Thereby, we came up with eight selected scale-ups,” explains Marco Billi, Corporate Venture and New Business Manager.
“It was a well thought out process that involved two phases. We had a first selection of 14 finalists, who introduced themselves to the assessment group and, out of these, eight were chosen for the program", says Luis Felipe Franco, head of Open Innovation at Endeavor.
To learn more about the program, visit www.eurofarmasynapsis.com.br.
About the Eurofarma Grupo
The Eurofarma Group is a healthcare company focused on offering products and services to improve people's lives with quality, innovation and fair price in the areas of Medical Prescription, Prescription Exempt, Generic, Hospital, Oncology and Veterinary. In Brazil alone, the company offers 287 products in 622 presentations, serves 30 medical specialties and covers 101 therapeutic classes, which represent 89% of pharmaceutical retail sales.
Founded in 1972 and as the first multinational pharmaceutical company with 100% Brazilian capital, it has its own operations in 20 countries, maintaining an important industrial site in Brazil and plants in 6 other Latin American countries. In 2018, the group generated sales of R$ 4.3 billion and employs more than 6.7 thousand employees.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma in the social networks
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
For Press Information
G&A – Public Relations
André Pascowitch - +55 11 5090-8646 - andre@gaspar.com.br
Guilherme Gaspar - +55 11 3065-3045 - guilherme@gaspar.com.br
About Endeavor
Endeavor is a global non-profit organization supporting high impact entrepreneurship. It acts in mobilizing public and private organizations and sharing practical knowledge and examples of high impact entrepreneurs to strengthen the entrepreneurial culture in the country.
In Brazil since 2000, it has helped generate nearly R$ 4 billion in revenue on an annually basis and over 20,000 direct jobs through entrepreneur support programs. Likewise, it fosters an environment that urges the growth and impact of entrepreneurs ahead of scale-ups, which are scalable and innovative high-growth companies.
Press Information
Amanda Freitas - +55 11 95232-1204 – amanda.freitas@endeavor.org.br
The selected companies presented solutions to contribute to process improvement and efficiency in healthcare chain productivity, focusing on Business Intelligence, shared services, commercial and marketing, industrial operations and sustainability. Below is a list of the chosen scale-ups:
| Scale-up | Description |
| DEV Tecnologia | Design House focused on IoT, engineering services and agile development of innovative products. |
| Trackage | Platforms and apps to monitor business asset flow and conditions, enabling process optimization and cost savings |
| ViaNuvem | Tool for modeling and publishing approval workflow / processes |
| PebMed | Efficient medical content inquiry tool and tools to assist healthcare professionals in clinical decision making |
| Laura | Technology that uses AI to identify which patients need immediate care by connecting electronic medical records and mining data |
| OnCase | One stop shop solutions for data. Own framework, which uses high performance optimization algorithms |
| DeskManager | Help Desk Management and Automation Software for HelpDesk, Service Desk, SAC and CSC |
| Nuveo | Proprietary platform offering end-to-end process automation solution |
From August, scale-ups will be mentored by Endeavor, a global non-profit organization that has been a partner of Eurofarma in the program for four months. Selected companies will be able to leverage their business by having industry information and trends available, coaching in support areas such as marketing, sales and logistics, and access to Eurofarma's relationship network. There are more than 4,000 suppliers, more than 1,500 active clients (B2B), almost 600,000 medical contacts per month and a presence with healthcare products and services in 20 Latin American countries. Then the chosen companies will start to implement a pilot project with Eurofarma so that they will have the opportunity to close a long-term contract later.
“We performed a careful assessment regarding the entrepreneur profile and its team, the degree of innovation and business model presented, considering the impact it can generate within Eurofarma. Thereby, we came up with eight selected scale-ups,” explains Marco Billi, Corporate Venture and New Business Manager.
“It was a well thought out process that involved two phases. We had a first selection of 14 finalists, who introduced themselves to the assessment group and, out of these, eight were chosen for the program", says Luis Felipe Franco, head of Open Innovation at Endeavor.
To learn more about the program, visit www.eurofarmasynapsis.com.br.
About the Eurofarma Grupo
The Eurofarma Group is a healthcare company focused on offering products and services to improve people's lives with quality, innovation and fair price in the areas of Medical Prescription, Prescription Exempt, Generic, Hospital, Oncology and Veterinary. In Brazil alone, the company offers 287 products in 622 presentations, serves 30 medical specialties and covers 101 therapeutic classes, which represent 89% of pharmaceutical retail sales.
Founded in 1972 and as the first multinational pharmaceutical company with 100% Brazilian capital, it has its own operations in 20 countries, maintaining an important industrial site in Brazil and plants in 6 other Latin American countries. In 2018, the group generated sales of R$ 4.3 billion and employs more than 6.7 thousand employees.
For more information, visit www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
Eurofarma in the social networks
Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br
For Press Information
G&A – Public Relations
André Pascowitch - +55 11 5090-8646 - andre@gaspar.com.br
Guilherme Gaspar - +55 11 3065-3045 - guilherme@gaspar.com.br
About Endeavor
Endeavor is a global non-profit organization supporting high impact entrepreneurship. It acts in mobilizing public and private organizations and sharing practical knowledge and examples of high impact entrepreneurs to strengthen the entrepreneurial culture in the country.
In Brazil since 2000, it has helped generate nearly R$ 4 billion in revenue on an annually basis and over 20,000 direct jobs through entrepreneur support programs. Likewise, it fosters an environment that urges the growth and impact of entrepreneurs ahead of scale-ups, which are scalable and innovative high-growth companies.
Press Information
Amanda Freitas - +55 11 95232-1204 – amanda.freitas@endeavor.org.br